Capricor Therapeutics (CAPR) Stock Chart & Stock Price History → Tech GIANT’s Plans to Revolutionize Crypto… (From Crypto 101 Media) (Ad) Free CAPR Stock Alerts $6.10 +0.11 (+1.84%) (As of 04:00 PM ET) Add Compare Share Share ChartStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrends Capricor Therapeutics Stock Price Performance5 Day Performance-1.32%1 Month Performance+10.72%3 Month Performance+38.34%6 Month Performance+102.36%Year-To-Date Performance+22.49%1 Year Performance+32.82% Receive CAPR Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Capricor Therapeutics and its competitors with MarketBeat's FREE daily newsletter Email Address Ad Wall Street StarThis Apple-like Innovator is Revolutionizing HealthcareAI has infiltrated so many sectors, it's sent the demand for AI-friendly GPU computer chips rocketing. Nvidia has gone up more than 3x in the past year. It is now valued well over $2 trillion, making it one of the largest companies in the world.Click here to learn more about the booming eHealth industry CAPR Stock Chart for Tuesday, May, 28, 2024 CAPR Chart by TradingView Capricor Therapeutics Share Price History Daily Weekly Monthly Time Frame Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year Time Frame * Start Date * End Date Export to Excel DateOpening PriceClosing PriceHighLowVolumeMarket Capitalization05/27/2024$5.99$5.99$6.07$5.90235,700 shs$190.54 million05/24/2024$6.07$5.99-1.32%$6.07$5.90233,813 shs$190.54 million05/23/2024$6.25$6.07-2.88%$6.25$6.02196,245 shs$193.09 million05/22/2024$6.29$6.25-0.64%$6.33$6.10322,059 shs$198.81 million05/21/2024$6.30$6.29-0.16%$6.34$6.03289,003 shs$200.09 million05/20/2024$6.20$6.30+1.61%$6.41$6.15404,354 shs$200.40 million Get the Latest News and Ratings for CAPR and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Capricor Therapeutics and its competitors with MarketBeat's FREE daily newsletter. 05/17/2024$5.64$6.20+9.93%$6.53$5.79755,108 shs$197.22 million05/16/2024$5.33$5.64+5.82%$5.80$5.27497,758 shs$177.66 million05/15/2024$5.20$5.33+2.50%$5.47$5.21284,210 shs$167.90 million05/14/2024$5.44$5.20-4.41%$5.47$5.00667,280 shs$163.80 million05/13/2024$5.30$5.44+2.64%$5.44$5.26193,629 shs$171.36 million05/10/2024$5.42$5.30-2.21%$5.50$5.23233,835 shs$166.97 million05/09/2024$5.37$5.42+0.93%$5.49$5.33111,219 shs$170.75 million05/08/2024$5.46$5.37-1.65%$5.48$5.25196,232 shs$169.17 million05/07/2024$5.53$5.46-1.27%$5.68$5.43362,751 shs$171.99 million05/06/2024$5.47$5.53+1.10%$5.57$5.45140,928 shs$174.20 million05/03/2024$5.24$5.47+4.39%$5.78$5.28259,829 shs$165.08 million05/02/2024$5.33$5.24-1.69%$5.40$5.20210,194 shs$165.06 million05/01/2024$5.27$5.33+1.14%$5.44$5.24171,034 shs$167.90 million04/30/2024$5.33$5.27-1.13%$5.48$5.16248,659 shs$166.01 million04/29/2024$5.41$5.33-1.48%$5.68$5.27447,877 shs$167.90 million04/26/2024$5.15$5.41+5.05%$5.49$5.12638,964 shs$170.42 million04/25/2024$5.04$5.15+2.18%$5.24$4.91387,928 shs$162.23 million04/24/2024$4.82$5.04+4.56%$5.65$5.00912,876 shs$158.78 million04/23/2024$4.94$4.82-2.43%$5.02$4.70478,470 shs$151.83 million04/22/2024$5.01$4.94-1.40%$5.11$4.92356,899 shs$155.61 million04/19/2024$5.05$5.01-0.79%$5.28$4.87354,006 shs$157.83 million04/18/2024$5.55$5.05-9.01%$5.65$4.69931,030 shs$159.08 million04/17/2024$5.93$5.55-6.41%$6.05$5.44477,863 shs$174.83 million04/16/2024$5.86$5.93+1.19%$6.03$5.71276,550 shs$186.80 million04/15/2024$6.25$5.86-6.24%$6.33$5.65344,645 shs$184.59 million04/12/2024$6.23$6.25+0.32%$6.29$6.03166,001 shs$196.88 million04/11/2024$6.30$6.23-1.11%$6.47$6.01372,854 shs$196.25 million04/10/2024$6.60$6.30-4.55%$6.71$6.06311,457 shs$198.45 million04/09/2024$6.58$6.60+0.30%$6.76$6.45225,826 shs$207.90 million04/08/2024$6.72$6.58-2.08%$6.80$6.54121,798 shs$207.27 million04/05/2024$6.70$6.72+0.30%$6.82$6.51269,154 shs$211.70 million04/04/2024$6.80$6.70-1.47%$7.00$6.69238,304 shs$211.05 million04/03/2024$6.89$6.80-1.31%$7.06$6.64165,655 shs$214.20 million04/02/2024$7.10$6.89-2.89%$7.07$6.85189,417 shs$217.04 millionWho are Nvidia’s New Silent Partners? (Ad)Nvidia recently became just the third $2 trillion company. But Nvidia can’t do everything by itself.I call these Nvidia’s “Silent Partners.”04/01/2024$6.79$7.10+4.49%$7.28$6.73413,944 shs$223.49 million03/29/2024$6.79$6.79$6.94$6.60185,085 shs$213.89 million03/28/2024$6.77$6.79+0.30%$6.94$6.60184,878 shs$213.89 million03/27/2024$6.31$6.77+7.29%$7.04$6.19382,685 shs$213.26 million03/26/2024$6.63$6.31-4.83%$6.68$6.21336,590 shs$198.77 million03/25/2024$6.38$6.63+3.92%$6.66$5.96444,366 shs$208.87 million03/22/2024$6.88$6.38-7.27%$6.76$5.80740,562 shs$200.33 million03/21/2024$6.85$6.88+0.44%$7.04$6.72415,171 shs$216.03 million03/20/2024$6.79$6.85+0.88%$6.93$6.45398,349 shs$215.09 million03/19/2024$6.76$6.79+0.44%$7.22$6.67926,711 shs$213.21 million03/18/2024$6.39$6.76+5.79%$6.91$6.10527,066 shs$212.26 million03/15/2024$6.17$6.39+3.57%$6.68$6.07499,833 shs$200.65 million03/14/2024$5.94$6.17+3.87%$6.36$5.83281,217 shs$189.97 million03/13/2024$5.90$5.94+0.68%$6.05$5.79162,782 shs$182.89 million03/12/2024$5.80$5.90+1.72%$5.95$5.50306,883 shs$181.66 million03/11/2024$5.89$5.80-1.53%$6.19$5.69656,119 shs$178.60 million03/08/2024$5.04$5.89+16.87%$5.89$4.97712,947 shs$181.35 million03/07/2024$5.18$5.04-2.70%$5.26$4.86271,895 shs$155.18 million03/06/2024$4.96$5.18+4.54%$5.28$4.96343,175 shs$159.51 million03/05/2024$4.67$4.96+6.10%$5.03$4.64272,772 shs$152.56 million03/04/2024$4.57$4.67+2.30%$4.78$4.57203,973 shs$143.79 million03/01/2024$4.20$4.57+8.69%$4.69$4.21385,261 shs$140.56 million02/29/2024$4.33$4.20-3.00%$4.48$4.10165,792 shs$129.32 million02/28/2024$4.34$4.33-0.23%$4.58$4.19142,643 shs$133.32 million02/27/2024$3.96$4.34+9.60%$4.61$4.06439,509 shs$133.63 million Related Companies: GALT Stock Chart PBYI Stock Chart OGI Stock Chart IVA Stock Chart VERU Stock Chart ATOS Stock Chart OMER Stock Chart ZVRA Stock Chart TRVI Stock Chart CDT Stock Chart Receive CAPR Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Capricor Therapeutics and its competitors with MarketBeat's FREE daily newsletter. This page (NASDAQ:CAPR) was last updated on 5/28/2024 by MarketBeat.com Staff From Our PartnersThis Apple-like Innovator is Revolutionizing HealthcareWall Street StarTech GIANT’s Plans to Revolutionize Crypto…Crypto 101 MediaDigitizing the $11T commodities sector with one tiny stockResource Stock DigestWARNING about the death of the U.S. dollar…Colonial MetalsThe only AI company to buyPorter & CompanyBiggest Prediction of My 50-Year Career on Wall StreetChaikin AnalyticsIs Artificial Intelligence the Biggest Bubble in History?InvestorPlaceExposed: 10 CENT Crypto to Explode May 20th?True Market Insiders Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Capricor Therapeutics Inc Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.